Japan DNA Vaccine Market will experience a noticeable growth during the forecast

Posted by pooja123 on April 10th, 2020

Japan DNA Vaccine market is anticipated to grow at a CAGR 41.6% during the forecast period.  Japan has significant growth in the DNA Vaccine market due to increase in prevalence of chronic disease and health care infrastructure with development of new technology. Among major global economies, Japan has the highest percentage of geriatric population. Various cancers are more commonly found in elderly age group. For instance, colon cancer accounts for more than 90% of individuals diagnosed over the age of 50. Similarly, stomach cancer accounts for about 60% of those diagnosed are over the age of 60.

In Japan, the vaccination of the children is not mandatory however the government has provided the guidelines and recommendations regarding vaccination. The government has notified that it is the duty of the parents to immunize their children from diseases. However, no penalty will be imposed on parents for not performing vaccination of their child.

Request a free sample of our report on Japan DNA Vaccine Market:  https://www.omrglobal.com/request-sample/japan-dna-vaccines-market

The market is segmented on the basis of type, application and technology. Based on type, the market is segmented into animal DNA vaccine and human DNA vaccine. Based on technology, the market is segmented into plasmid DNA vaccine and plasmid DNA delivery. Based on application, the market is segmented into oncology, infectious disease and others.

The key market players that are active in the market include Asteel Pharma, Inc., Eli Lilly and Co., GE Healthcare, Glaxosmithkline PLC., Inovio Pharmaceuticals Inc., Merck & Co., Novartis AG, Pfizer Inc., Roche Diagnostics GMBH and Sanofi Inc. The market players are considerably contributing to the market growth by the adoption of various strategies including new product launch, merger, and acquisition, collaborations with government, funding to the start-ups and technological advancements to stay competitive in the market. Moreover, Japanese company Astellas Pharma Inc is developing the DNA vaccine for the pollinosis that is due to Japanese red cedar. The DNA vaccine is in the phase II trials.

A full report of Japan DNA Vaccine Market is available at:  https://www.omrglobal.com/industry-reports/japan-dna-vaccines-market

Japan  DNA Vaccine Market Segmentation

By Type

  • Animal DNA Vaccine

  • Human DNA Vaccine

By Technology

  • Plasmid DNA Vaccine 

  • Plasmid DNA Delivery 

By Application

  • Oncology

  • Infectious Disease

  • Others

Company Profiles

  • Asteel Pharma, Inc

  • Eli Lilly and Co.

  • GE Healthcare

  • Glaxosmithkline PLC.

  • Inovio Pharmaceuticals Inc. 

  • Merck & Co.

  • Novartis AG

  • Pfizer Inc.

  • Roche Diagnostics GMBH

  • Sanofi Inc.


About us:

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com  

Contact no: +1 646-755-7667, +91 780-304-0404




Binary Options Trading Signals
BOTS room has been around for over 6 years and is the community everyone uses for strategy development for options and Forex. With market veterans with over 20 years experience, what could be better!
Advertise Here